AINDEX
Markets

Haemonetics Corporation (HAE)

HAENYSEMedical/Dental Instruments

$121.34

0.0000 (0.00%) today

Pre-market, Nov 16, 4:00 PM ET

-3.76% 1D
Market cap
$5.53bn
P/E
23.8
EPS, last 4 quarters
$5.09
Dividend yield
–
Day range
–
52-week range
$51.00 to $132.00
Average volume
–
Previous close
$121.34

Analysts

9 covering

Buy7 buy, 2 hold, 0 sell

Targets a year out average $145.56, +20.0% from here

$125.00now $121.34$165.00

Earnings

next estimate $1.26

Next report

Dec 2025

+3.1%

Mar 2026

+0.8%

Jun 2026

+6.5%

Sep 2026

+3.9%

estimate reported, and the surprise

Financials

QuarterDec 2025Mar 2026Jun 2026Sep 2026
Revenue$338.97m$346.35m$339.38m$357.76m
Gross profit$202.39m$198.21m$202.80m$220.91m
Operating income$67.40m-$23.02m$57.46m$75.12m
Net income$44.74m-$20.15m$33.01m$46.30m

Last four quarters: revenue $1.38bn, margin 7.5%, free cash flow $259.84m

News

8 latest

The company

Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our Apheresis business features proprietary technologies designed to enhance safety, yield, donor satisfaction and operational efficiency for plasma and blood collectors around the world. Our MedSurg business offers Blood Management Technologies to help inform treatment decisions and optimize the management of blood products, and Interventional Technologies, including advanced vascular closure systems and sensor-guided technologies, designed to drive procedural effectiveness and elevate the patient experience.

Sector
Health Care
Industry
Medical/Dental Instruments
Exchange
NYSE
Region
North America

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.

Haemonetics Corporation (HAE) price, chart and news · AINDEX